Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study

In a large, refractory, real-world CD population, RZB induced rapid and sustained favorable clinical, endoscopic, and radiologic outcomes. Importantly, one-year effectiveness was similar in patients with 2, and ≥3 previous failures, supporting RZB as a valuable option for a refractory population.

Authors

Institutions

Publication Details

Journal
The American Journal of Gastroenterology
Published
2026-02-18
DOI
https://doi.org/10.14309/ajg.0000000000003969
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study

Antonietta Gerarda Gravina, Emma Calabrese, Alice De Bernardi, A. Di Sario et al.
The American Journal of Gastroenterology
Inflammatory Bowel Disease
article

Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study

Antonietta Gerarda Gravina, Emma Calabrese, Alice De Bernardi, A. Di Sario, L. Laterza, F.R. De Filippo, Fabrizio Santagata, Dhanai Di Paolo, Viviana Gerardi, Maria Francesca Onidi, Roberto Gabbiadini, M. Ascolani, Marco Mendolaro, M. Cappello, Paola Balestrieri, Lorenzo Bertani, Davide Giuseppe Ribaldone, S. Onali, Emiliano Giangreco, Fernando Rizzello, Alessandra Piagnani, M. Merli, Antonio Rispo, Fabrizio Bossa, R Cannatelli, F Desideri, A Variola, M Aloi, M Cicala, A Tursi, Luca Pastorelli, Chiara Viganò, Giorgia Bodini, Federica Di Vincenzo, Silvio Danese, Edoardo Vincenzo Savarino, Flavio Caprioli, on behalf of the RESOLVE Study Group (Mariangela Allocca; Annalisa Aratari; Michele Campigotto; Pietro Capone; Giuseppe Cuccia; Elena Del Zanna; Elisa Foscarini; Federica Furfaro; Alfredo Greco; Alba Panarese; Raffaele Pellegrino; Roberta Pica; Francesca Profeta; Ivan Salerno, Simone Saibeni, Enrico Tettoni), Ferdinando D’Amico, Daniela Pugliese, Cristina Bezzio, Franco Scaldaferri, Gionata Fiorino, Mauro Mastronardi, Alessandro Armuzzi, Loris Riccardo Lopetuso, Irene Marafini, Giammarco Mocci, Massimo Claudio Fantini, Rocco Spagnuolo
article en

Abstract

In a large, refractory, real-world CD population, RZB induced rapid and sustained favorable clinical, endoscopic, and radiologic outcomes. Importantly, one-year effectiveness was similar in patients with 2, and ≥3 previous failures, supporting RZB as a valuable option for a refractory population.

The American Journal of Gastroenterology
Università Cattolica del Sacro Cuore (IT), University of Rome Tor Vergata (IT), AOL (United States) (US), Humanitas University (IT), University of Padua (IT), École nationale des ponts et chaussées (FR), Vita-Salute San Raffaele University (IT), Università Campus Bio-Medico (IT), Casa Sollievo della Sofferenza (IT), Fondazione Roma (IT), Agostino Gemelli University Polyclinic (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Magna Graecia University (IT), Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT), Ospedale Maggiore (IT), Ospedale di Bolzano (IT), Azienda Ospedaliera San Camillo-Forlanini (IT), IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT), Ospedale San Filippo Neri (IT), Ospedale Sacro Cuore Don Calabria (IT), Department of Medical Sciences (RU), Centro Clinico Nemo (IT), Alessandro Manzoni Hospital (IT), Federico II University Hospital (IT), Presidio Ospedaliero (IT), Azienda Ospedaliero-Universitaria Cagliari (IT), University of Campania "Luigi Vanvitelli" (IT), General Hospital of Rhodes (GR), A. O. Ordine Mauriziano di Torino (IT), Accademia di Belle Arti di Catanzaro (IT), IRCCS Ospedale San Raffaele (IT), Ospedali Riuniti San Giovanni di Dio e Ruggi d'Aragona (IT), Azienda Ospedaliera Universitaria Senese (IT), Nini Hospital (LB), University of Palermo (AR), Civil Service (GB), Campus Bio Medico University Hospital (IT), Ospedale Maria Vittoria (IT), Ca' Foncello Hospital (IT), Ospedale Policlinico San Martino (IT), Azienda Ospedale - Università Padova (IT), Fondazione Poliambulanza Istituto Ospedaliero (IT), Ospedale Sant'Anna (IT), Carlo Forlanini Hospital (IT), Gastroenterology Hospital "Saverio de Bellis" (IT), ASST Fatebenefratelli Sacco (IT), Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco" (IT), Ospedale Valduce (IT), IRCCS Humanitas Research Hospital (IT), Azienda Ospedaliera G. Brotzu (IT), Link Campus University (IT), University of Bari Aldo Moro (IT), University of Milano-Bicocca (IT), University of Naples Federico II (IT), Sapienza University of Rome (IT), University of Palermo (IT)
Good health and well-being
Openalex Percentile: Top 49%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.